Clinical Studies

The effect and benefits of Iscador® have been extensively researched for years and are the subject of ongoing scientific studies and articles. Below you will find the full text of some recently published studies. Abstracts of additional studies can be found on PubMed.

A 2010 Documentation of published clinical studies with Iscador® can be accessed at the Hiscia Research Institute website.

Use of Iscador®, an Extract of European Mistletoe (Viscum Album), in Cancer Treatment.
A major 30-year-long study with more than 35,000 participants reports that extract of mistletoe (Iscador®) greatly improves survival rate for a wide variety of cancers, including breast cancer. Study participants who augmented conventional therapy with mistletoe extract survived 40% longer compared with those who didn’t use the plant therapy.
Long-term Adjuvant Treatment of Primary Intermediate to High-Risk Malignant Melanoma
A long-term Iscador treatment in patients with mean- to high-risk primary malignant melanoma appears to be safe. A tumor enhancement was not observed. In comparison with an untreated parallel control group from the same cohort the results of the mistletoe treatment show a significant survival advantage in the UICC-/AJCC stages II-III.
Changes in Immunological Characteristics of White Blood Cells after ... Part II
After administering standardized mistletoe extract, Iscador®, the investigations showed a temporarily improved function of the microcirculation and an increased adhesion and transmigration of white blood cells in the target tissue areas. (article in 3 parts)
Changes in Immunological Characteristics of White Blood Cells after ... Part III
After administering standardized mistletoe extract, Iscador®, the investigations showed a temporarily improved function of the microcirculation and an increased adhesion and transmigration of white blood cells in the target tissue areas. (article in 3 parts)
Changes in Immunological Characteristics of White Blood Cells after Administration of Standardized Mistletoe Extract … Part I
After administering standardized mistletoe extract, Iscador®, the investigations showed a temporarily improved function of the microcirculation and an increased adhesion and transmigration of white blood cells in the target tissue areas. (article in 3 parts)
Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro
The results show no evidence of stimulation of tumor growth by any of the three Iscador® preparations, comprising central nervous system, gastric, non-small cell lung, mammary, prostate, renal and uterine cancer cell lines, as well as cell lines from hematological malignancies and melanomas.
Mistletoe - Introducing an unusual plant
Information about Mistletoe: Harvesting and cultivation, sexes, reproduction and germination.
Mistletoe improves tolerability of breast cancer treatment
Multicenter Cohort Study. Adjuvant treatment with mistletoe extract can increase the tolerability of conventional cancer treatment, improve patient quality of life, and lengthen tumor free survival, Dr. Paul R. Bock reported.
Mistletoe Complementary Treatment in Patients with Primary Non-metastatic Breast Cancer
The results of the present study confirmed the safety of the complementary therapy for patients with primary, non-metastatic mammary carcinoma with Iscador® and showed considerably fewer ADRs attributed to concurrent conventional therapy, as well as reduced disease and treatment-associated symptoms, and suggested a prolonged overall survival in the Iscador® group as compared with controls.
Iscador Qu for chronic hepatitis C: an exploratory study
Iscador may have potential as a non toxic therapy for chronic hepatitis C treatment.
Heartbeat rhythms and oscillations
An important aspect of the current work and research conducted by the Department of Clinical research at Herdecke Hospital in Germany is the development and application of methods to explore the rhythms/oscillations of heartbeat and respiration of the human organism. This link leads to a list of additional studies on this theme. Go to 'Publications' on the webpage of the Herdecke Hospital.
Cardio-Respiratory Regulations
Conclusions: WELEDA Cardiodoron stimulates the regulation of cardiorespiratory interaction during nighttime sleep. Furhtermore, improved mormalization indicates a general improvement of the regulatory processes of functional rhythms. (Altern Ther Health Med. 2002; 8(6): 78-83).
For more clinical articles and published research on anthroposophic medicine, please visit the AnthroMed Library.
Skip Navigation LinksClinical Studies